KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Revenue (2016 - 2025)

National Health Investors (NHI) has disclosed Revenue for 17 consecutive years, with $30.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 155.7% year-over-year to $30.7 million, compared with a TTM value of $80.1 million through Dec 2025, up 47.12%, and an annual FY2025 reading of $80.1 million, up 47.12% over the prior year.
  • Revenue was $30.7 million for Q4 2025 at National Health Investors, up from $21.2 million in the prior quarter.
  • Across five years, Revenue topped out at $82.9 million in Q3 2024 and bottomed at -$107.2 million in Q3 2022.
  • Average Revenue over 5 years is $32.1 million, with a median of $26.0 million recorded in 2025.
  • The sharpest move saw Revenue surged 573.95% in 2023, then plummeted 169.43% in 2024.
  • Year by year, Revenue stood at $69.7 million in 2021, then crashed by 83.08% to $11.8 million in 2022, then soared by 573.95% to $79.5 million in 2023, then tumbled by 169.43% to -$55.2 million in 2024, then surged by 155.7% to $30.7 million in 2025.
  • Business Quant data shows Revenue for NHI at $30.7 million in Q4 2025, $21.2 million in Q3 2025, and $14.2 million in Q2 2025.